NCT03500562View on ClinicalTrials.gov

Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

March 29, 2019

Study Completion Date

March 29, 2019

Conditions
Chronic Hepatitis C
Trial Locations (2)

100054

Local Institution, Beijing

510515

Local Institution, Guangzhou

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03500562 - Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC) | Biotech Hunter | Biotech Hunter